Decoding Oligonucleotide Stereochemistry: Individual Phosphorothioate Configuration Ratios and Intact Sequence
Md Rabiul Islam1, Leonard Yoon1, Nadia Tasnim Ahmed1
1Division of Pharmaceutical Quality Research II, Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States.
High-resolution ion mobility mass spectrometry (HRIM-MS) enables simultaneous stereochemical analysis of oligonucleotide therapeutics. This method reveals discrepancies between intact sequence diastereomers and individual linkage configurations, crucial for drug quality and comparability.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Science
- Biotechnology
Background:
- Phosphorothioate (PS) modifications in oligonucleotide therapeutics create complex diastereomeric mixtures.
- Stereochemical characterization is vital for drug development, regulatory approval, and generic comparability.
- Current analytical methods struggle with simultaneous, multi-level stereochemical analysis.
Purpose of the Study:
- To develop and demonstrate a high-resolution ion mobility mass spectrometry (HRIM-MS) methodology for concurrent stereochemical analysis of oligonucleotide therapeutics.
- To enable simultaneous characterization at both the intact sequence and individual PS linkage levels.
- To investigate potential discrepancies between intact sequence diastereomeric composition and individual PS linkage configurations.
Main Methods:
- Utilized high-resolution ion mobility mass spectrometry (HRIM-MS).
- Employed a phosphorothioate (PS)-modified 3-mer oligonucleotide as a model system.
- Performed in-source fragmentation to analyze individual PS linkages.
Main Results:
- Achieved baseline separation of all four expected diastereomers of the 3-mer sequence.
- Enabled direct measurement of intact sequence diastereomeric composition.
- Directly quantified Rp/Sp configuration ratios at individual PS linkages.
- Observed discrepancies between intact sequence diastereomeric profiles and predicted compositions based on individual linkage ratios.
Conclusions:
- HRIM-MS provides unprecedented concurrent stereochemical analysis of oligonucleotide therapeutics at multiple levels.
- Intact diastereomeric composition may not be predictable from individual PS linkage configurations alone.
- Comprehensive, multi-level stereochemical characterization is essential for ensuring quality, consistency, and comparability of oligonucleotide therapeutics.
Related Concept Videos
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Phosphodiester Linkages
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
Stereoisomers
SN2 Reaction: Stereochemistry
If the substrate is an achiral molecule at the α-carbon, the inversion of configuration is not observed.
Stereoisomerism of Cyclic Compounds


